Nobuhiro Hanai

9PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 29, 2026
A multicenter randomized phase III trial to evaluate the value of omission of elective neck dissection for T3-T4aN0 laryngeal cancer: JCOG2407 (JALNECK).

|Jun 26, 2026
Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.

|Jun 24, 2026
A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

|Jun 22, 2026
Current status and future perspectives of treatment de-escalation in localized head and neck cancer.

|Apr 13, 2026
Non-surgical definitive treatment and geriatric assessment in older patients with locally advanced head and neck cancer.

Koichi Yasuda, Yoshitaka Honma, Yuri Ueda

|Sep 30, 2024
Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008.

Yoshinori Imamura, Naomi Kiyota, Makoto Tahara

Pageof 2

Frequent Collaborators

6 joint publications

Naomi Kiyota

4 joint publications

Takeshi Kodaira

3 joint publications

Naoki Nishio

3 joint publications

Keita Sasaki